| Product Code: ETC11272494 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market - Industry Life Cycle |
3.4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market - Porter's Five Forces |
3.5 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular and neurological disorders in Ireland |
4.2.2 Technological advancements in in-vitro diagnostics for cardiology and neurology |
4.2.3 Growing awareness about early disease detection and diagnosis |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diagnostic tests |
4.3.2 High cost associated with advanced diagnostic technologies |
4.3.3 Limited access to healthcare facilities in remote areas of Ireland |
5 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Trends |
6 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market, By Types |
6.1 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Cardiac Biomarkers, 2021 - 2031F |
6.1.4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurological Biomarkers, 2021 - 2031F |
6.1.5 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Genetic Markers, 2021 - 2031F |
6.1.6 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Troponin, 2021 - 2031F |
6.2.3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Amyloid Beta, 2021 - 2031F |
6.2.4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By APOE Testing, 2021 - 2031F |
6.3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Heart Attack Detection, 2021 - 2031F |
6.3.3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Alzheimer's Diagnosis, 2021 - 2031F |
6.3.4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Stroke Risk Assessment, 2021 - 2031F |
6.3.5 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Neurodegenerative Disorders, 2021 - 2031F |
6.4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.4.4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4.5 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Import-Export Trade Statistics |
7.1 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Export to Major Countries |
7.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Imports from Major Countries |
8 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Key Performance Indicators |
8.1 Adoption rate of in-vitro diagnostics in cardiology and neurology practices |
8.2 Average turnaround time for diagnostic test results |
8.3 Rate of accuracy in diagnostic test results |
8.4 Number of partnerships and collaborations for research and development in the field |
8.5 Level of patient satisfaction with diagnostic services provided |
9 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market - Opportunity Assessment |
9.1 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market - Competitive Landscape |
10.1 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Revenue Share, By Companies, 2024 |
10.2 Ireland In-Vitro Diagnostics for Cardiology and Neurology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here